The effect of Betanin parenteral pretreatment on Jejunal and pulmonary tissue histological architecture and inflammatory response after Jejunal ischemia-reperfusion injury.


Journal

Experimental and molecular pathology
ISSN: 1096-0945
Titre abrégé: Exp Mol Pathol
Pays: Netherlands
ID NLM: 0370711

Informations de publication

Date de publication:
10 2019
Historique:
received: 19 03 2019
revised: 10 07 2019
accepted: 31 07 2019
pubmed: 5 8 2019
medline: 28 2 2020
entrez: 5 8 2019
Statut: ppublish

Résumé

Intestinal ischemic-reperfusion (IR) injury has detrimental effects on both local and distant organs in the body. Betanin is known for its antioxidant properties, and it is found mostly in vegetables. Therefore, the aim of the present study was to test the hypothesis that betanin administration prior intestinal IR, may be beneficial in protecting jejunal mucosa and lung parenchyma against IR damage. Male specific pathogen-free Charles River Wistar rats were used (n = 42). Betanin (50 mg/kg) was administered intraperitoneally 30 min before ischemia of the superior mesenteric artery lasting 1 h, followed by 1, 4 and 24 h of reperfusion. Immunohistochemical as well as histomorphometrical analysis indicated a protective effect of betanin pretreatment on jejunal tissue. Regarding morphometrical analysis betanin significantly (p < 0.01) augments intestinal villus height after 24 of reperfusion comparing to early stages. Betanin application reduced number of mast cells population in early reperfusion periods (p < 0.05). The protective effect of betanin on lung parenchyma, was detected in late reperfusion period (24 h) with improvement of histopathological injury index and morphometric analysis (p < 0.001 for both). The improvement of histopathological injury index (p < 0.001) and morphometric analysis (p < 0.001) during the late reperfusion period, suggests a protective effect of betanin on lung parenchyma. Moreover, suppression of the inflammatory response was mirrored by the reduction of myeloperoxidase (MPO) positive cells within lung parenchyma after 1 and 4 h of reperfusion (p < 0.001). Especially, during the first 4 h of reperfusion after betanin administration, a reduction of 74% of the polymorphonuclear neutrophils infiltration (MPO positive cell population) and of a nearly 46% of active MCs was observed. Upon morphometric examination, the lung histological architecture after 24 h of reperfusion appeared to be almost 100% better following betanin treatment, with 25% thinner interalveolar septa and 20% larger alveolar surface for respiratory gas exchange. The results suggest that betanin pretreatment protects the jejunal mucosa and the lung parenchyma, as well as reduces the inflammatory cell density after intestinal IR injury.

Identifiants

pubmed: 31377235
pii: S0014-4800(19)30201-1
doi: 10.1016/j.yexmp.2019.104292
pii:
doi:

Substances chimiques

Betacyanins 0
betanin 5YJC992ZP6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104292

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Stefan Toth (S)

Department of Histology and Embryology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.

Zuzana Jonecova (Z)

Department of Histology and Embryology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.

Milan Maretta (M)

Department of Neurology and Center for Rare Movement Disorder, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.

Kristina Curgali (K)

Department of Histology and Embryology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.

Theodoros Kalpakidis (T)

Department of Histology and Embryology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.

Martin Pribula (M)

Department of Histology and Embryology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.

Matus Kusnier (M)

Department of Histology and Embryology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.

Zuzana Fagova (Z)

Department of Histology and Embryology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.

Julia Fedotova (J)

Laboratory of Neuroendocrinology, I.P. Pavlov Institute of Physiology, Russian Academy of Sciences, St. Petersburg, Russia; Department of Chemistry and Molecular Biology, ITMO University, St. Petersburg, Russia.

Giampiero La Rocca (G)

Human Anatomy Section, Department of Experimental Biomedicine and Clinical Neurosciences, University of Palermo and Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy.

Luis Rodrigo (L)

Faculty of Medicine, University of Oviedo, Central University Hospital of Asturias (HUCA), Oviedo, Spain.

Martin Caprnda (M)

1st Department of Internal Medicine, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia.

Anthony Zulli (A)

Institute for Health and Sport, Victoria University, Footscray, Australia.

Rachele Ciccocioppo (R)

Gastroenterology Unit, Department of Medicine, AOUI Policlinico G.B. Rossi, University of Verona, Italy.

Eva Mechirova (E)

Department of Histology and Embryology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.

Peter Kruzliak (P)

Department of Internal Medicine, Borthers of Mercy Hospital, Brno, Czech Republic; 2nd Department of Surgery, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Brno, Czech Republic. Electronic address: kruzliakpeter@gmail.com.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH